Butabarbital will lessen the level or impact of fedratinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Impact of coadministering a strong CYP3A4 inducer with fedratinib hasn't been studied. butabarbital will minimize the extent or influence of aprepitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use https://scottj802hlo8.weblogco.com/profile